Results 21 to 30 of about 9,924,949 (260)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report

open access: yesFrontiers in Oncology, 2021
Microsatellite instability-high (MSI-H) is widely believed to be a biomarker for immune checkpoint inhibitors (ICIs) such as pembrolizumab in solid tumors.
Tian Zeng   +11 more
doaj   +1 more source

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

open access: yesExploration of Targeted Anti-tumor Therapy, 2023
A clinical case of a 61-year-old female diagnosed with stage IV right colon adenocarcinoma (unresectable liver and multiple lymph node metastases at the time of diagnosis), Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma rat sarcoma ...
Celia Lara-Morga   +4 more
doaj   +1 more source

Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response

open access: yesOncoImmunology, 2020
After neoadjuvant chemoradiotherapy for esophageal adenocarcinoma, up to 29% of patients have a pathological complete response (pCR). What to do afterward is still under debate.
Andromachi Kotsafti   +12 more
doaj   +1 more source

A prospective randomized comparison of concurrent chemoradiation with neoadjuvant and adjuvant chemotherapy with concurrent chemoradiation alone for locally advanced carcinoma cervix

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Aims: The aim of this study was to compare concurrent chemoradiation along with neoadjuvant and adjuvant chemotherapy versus concurrent chemoradiation alone in locally advanced cervical cancer regarding treatment response and toxicities.
Rahul Singh   +10 more
doaj   +1 more source

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma

open access: yesGut and Liver, 2017
Background/AimsTo investigate the predictive factors for complete response (CR) and recurrence after CR in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE).Methods : Among 691 newly diagnosed HCC patients ...
Shin Ok Jeong   +13 more
doaj   +1 more source

The effect of tislelizumab on complete and pathological complete response in non-small cell lung cancer: a systematic review and meta-analysis

open access: yesFrontiers in Oncology
BackgroundImmune checkpoint inhibitors have transformed non-small cell lung cancer (NSCLC) treatment, and while overall survival (OS) and progression-free survival (PFS) are well-established, a comprehensive meta-analysis focusing on complete response ...
Qian Feng   +6 more
doaj   +1 more source

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

open access: yesFrontiers in Oncology, 2022
Assessment of minimal residual disease (MRD) is becoming a standard diagnostic tool for curable hematological malignancies such as chronic and acute myeloid leukemia. Multiple myeloma (MM) remains an incurable disease, as a major portion of patients even
Valeria Ferla   +12 more
doaj   +1 more source

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma

open access: yesCancer Medicine, 2020
Microsatellite instability (MSI) has been investigated as a prognostic and predictive factor for chemotherapy in colorectal cancer and has recently been demonstrated to be predictive of the PD‐1/PD‐L1 checkpoint blockade response in various solid tumors.
Tian Tian   +5 more
doaj   +1 more source

the ultimate in pleasurable reading [PDF]

open access: yes, 1989
This is the Climax magazine of September 13, 1989, Vol. 2, No. 7.• Maryam and her baby. • Adan's dream girl. • Me, to be Nigeria’s president? No. way – By Mary Onyali, African Queen of tracks. • Holyland where miracles are performed.
COMPLETE Communications limited
core   +8 more sources

Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: Experience from a single institution

open access: yesJournal of Cardiothoracic Surgery, 2011
Background Surgical treatment for pulmonary metastases is known to be a safe and potentially curative procedure for various primary malignancies. However, there are few reports regarding the prognostic role of surgical treatment for pulmonary metastases ...
Ogawa Hirofumi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy